Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample

Psychiatry Research

Volumn 239, Issue , 2016, Pages 245-252

  Sawaya, Helen ^a   Atoui, Mia ^a   Hamadeh, Aya ^a   Zeinoun, Pia ^a   Nahas, Ziad ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Anxiety; Arabic; Depression; Lebanon; Scale; Screening; Validation

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURAL FACTOR; DISCRIMINANT VALIDITY; DISEASE SEVERITY; DSM-IV-TR; FACTORIAL ANALYSIS; FEMALE; GENERALIZED ANXIETY DISORDER 7 QUESTIONNAIRE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTERNAL CONSISTENCY; LEBANESE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PATIENT HEALTH QUESTIONNAIRE 9; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TEST RETEST RELIABILITY; VALIDATION PROCESS; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; DEVICES; LEBANON; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; REPRODUCIBILITY; STANDARDS; VALIDATION STUDY;

ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LEBANON; MALE; MIDDLE AGED; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES;

EID: 84961642190     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.03.030     Document Type: Article

References (78)

1. Alansari B.M. Beck depression inventory (BDI-II) items characteristics among undergraduate students of nineteen Islamic countries. Soc. Behav. Personal. 2005, 33:675-684.
2. Alansari B.M. Internal consistency of an Arabic adaptation of the Beck depression inventory - II with college students in eighteen Arab countries. Soc. Behav. Personal. 2006, 34:425-430.
3. Al-Musawi N.M. Psychometric properties of the Beck depression inventory - II with university students in Bahrain. J. Pers. Assess. 2001, 77:568-579.
4. Al-Turkait F.A., Ohaeri J.U., El-Abbasi A.H., Naguy A. Relationship between symptoms of anxiety and depression in a sample of Arab college students using the Hopkins Symptom Checklist 25. Psychopathology 2011, 44:230-241.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Press, Washington, DC. 4th edition.
6. Azah N.M.N., Shah M.M.E., Juwita S., Bahri S.I., Rushidi W.M.W.M., Jamil M.Y. Validation of the Malay version brief Patient Health Questionnaire (PHQ-9) among adult attending family medicine clinics. Int. Med. J. 2005, 12:259-263.
7. Balsamo M., Romanelli R., Innamorati M., Ciccarese G., Carlucci L., Saggino A. The state-trait anxiety inventory: shadows and lights on its construct validity. J. Psychopathol. Behav. Assess. 2013, 35:475-486.
8. Becker S., Zaid K.A., Faris E. Screening for somatization and depression in Saudi Arabic: a validation study of the PHQ in primary care. Int. J. Psychiatry Med. 2002, 32:271-283.
9. Becker S.M. Detection of somatization and depression in primary care in Saudi Arabia. Soc. Psychiatry Psychtr. Epidemiol. 2004, 39:962-966.
10. Beshai S., Dobson K.S., Adel A. Psychometric properties of the center for epidemiologic studies depression scale in an Egyptian student sample: a preliminary report. MECPsych 2013, 20:223-228.
11. Cameron I.M., Crawford J.R., Lawton K., Reid I.C. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br. J. Gen. Pract. 2008, 58. 32-26.
12. Cameron, I.M., Crawford, J.R., Lawton, K., Sumit, S., Du Toit, S., Hay, S., Reid, I.C., 2011. Assessing the validity of the PHQ-9, HADS, BDI-II and QIDS-SR16 in measuring severity of depression in a UK sample of primary care patients with a diagnosis of depression. NHS Quality Improvement Scotland.
13. Cannon D.S., Tiffany S.T., Coon H., Scholand M.B., McMahon W.M., Leppert M.F. The PHQ-9 as a brief assessment of lifetime major depression. Psychol. Assess. 2007, 19:247-251.
14. Carballeira Y., Dumont P., Borgacci S., Rentsch D., Tonnac N., Archinard M., Andreoli A. Criterion validity of the French version of Patient Health Questionnaire (PHQ) in a hospital department of internal medicine. Psychol. Psychother-T. 2007, 80:69-77.
15. çorapçioglu A., özer G.U. Adaptation of revised Brief PHQ (Brief-PHQ-r) for diagnosis of depression, panic disorder and somatoform disorder in primary healthcare settings. Int. J. Psychiatry Clin. Pract. 2004, 8:11-18.
16. Daradkeh T.K., Eapen V., Ghubash R. Mental morbidity in primary care in Al Ain (UAE): application of the Arabic translation of the PRIME-MD (PHQ) version. Ger. J. Psychiatry 2005, 8:32-35.
17. Dbouk N., Arguedas M.R., Sheikh A. Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C. Dig. Dis. Sci. 2008, 53:1100-1106.
18. Dear B.F., Titov N., Sunderland M., McMillan D., Anderson T., Lorian C., Robinson E. Psychometric comparison of the Generalized Anxiety Disorder Scale-7 and the Penn State Worry Questionnaire for measuring response during treatment of generalised anxiety disorder. Cogn. Behav. Ther. 2011, 40:216-227.
19. Delgadillo J., Payne S., Gilbody S., Godfrey C., Gore S., Jessop D., Dale V. Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depend. 2012, 125:37-42.
20. Diez-Quevedo C., Rangil T., Sanchez-Planell L., Kroenke K., Spitzer R.L. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish Inpatients. Psychosom. Med. 2001, 63:679-686.
21. Donker T., van Straten A., Marks I., Cuijpers P. Quick and easy self-rating of Generalized Anxiety Disorder: Validity of the Dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res. Psychiatry Res. 2011, 188:58-64.
22. Donnelly P.L. The use of the Patient Health Questionnaire-9 Korean version (PHQ-9K) to screen for depressive disorders among Korean Americans. J. Transcult. Nurs. 2007, 18:324-330.
23. Dum M., Pickren J., Sobell L.C., Sobell M.B. Comparing the BDI II and the PHQ-9 with outpatient substance abusers. Addict. Behav. 2008, 33:381-387.
24. Eack S.M., Greeno C.G., Lee B.J. Limitations of the patient health questionnaire in identifying anxiety and depression in community mental health: many cases are undetected. Res. Soc. Work Prac. 2006, 16:625-631.
25. El-Rufaie O.E.F., Absood G.H. Retesting the validity of the Arabic version of the hospital anxiety and depression (HAD) scale in primary health care. Soc. Psychiatry Psychiatr. Epid. 1995, 30:26-31.
26. El-Rufaie O.E.F., Absood G.H., Abou-Saleh M.T. The primary care anxiety and depression (PCAD) scale: a culture-oriented screening scale. Acta Psychiatr. Scand. 1997, 95:119-124.
27. Feldman L.A. Distinguishing depression and anxiety in self-report: evidence from confirmatory factor analysis on nonclinical and clinical samples. J. Consult. Clin. Psychol. 1993, 61:631-638.
28. Fydrich T., Dowdall D., Chambless D.L. Reliability and validity of the Beck Anxiety Inventory. J. Anxiety Disord. 1992, 6:55-61.
29. García-Campayo J., Zamorano E., Ruiz M.A., Pardo A., Pérez-Páramo María, López-Gómez V., Freire O., Rejas J. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. BMC 2010, 8:1-11.
30. Geisinger K.F. Cross-cultural normative assessment: Translation and adaptation issues influencing the normative interpretation of assessment instruments. Psychol. Assess. 1994, 6:304-312.
31. Gelaye B., Williams M.A., Lemma S., Deyessa N., Bahretibeb Y., Shibre T., Wondimagegn D., Lemenhe A., Fann J.R., Stoep A.V., Zhou X.H.A. Validity of the patient health questionnaire-9 for depression screening and diagnosis in East Africa. Psychiatry Res. 2013, 210:653-661.
32. Ghubash R., Daradkeh T.K., Al Naseri K.S., Al Bloushi N.B., Al Daheri A.K. The performance of the center for epidemiologic study depression scale (CES-D) in an Arab female community. Int. J. Soc. Psychiatry 2000, 46:241-249.
33. Gilbody S., Richards D., Brealey S., Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J. Gen. Intern. Med. 2007, 22:1596-1602.
34. Hariz N., Bawab S., Atwi M., Tavitian L., Zeinoun P., Khani M., Birmaher B., Nahas Z., Maalouf F.T. Reliability and validity of the Arabic screen for child anxiety related emotional disorders (SCARED) in a clinical sample. Psychiatry Res. 2013, 209:222-228.
35. Hepner K.A., Hunter S.B., Edelen M.O., Zhou A.J., Watkins K. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. J. Subst. Abus. Treat. 2009, 37:318-325.
36. Hijazi Z., Weissbecker I., Chammay R. The integration of mental health into primary health care in Lebanon. Intervention 2011, 9:265-278.
37. Huang F.Y., Chung H., Kroenke K., Delucche K.L., Spitzer R.L. Using the patient health questionnaire - 9 to measure depression among racially and ethnically diverse primary care patients. J. Gen. Intern. Med. 2006, 21:547-552.
38. Inagaki M., Ohtsuki T., Yonemoto N., Kawashima Y., Saitoh A., Oikawa Y., Kurosawa M., Muramatsu K., Furukawa T.A., Yamada M. Validity of the Patient Health Questionnaire (PHQ)-9 and PHQ-2 in general internal medicine primary care at a Japanese rural hospital: a cross-sectional study. Gen. Hosp. Psychiatr. 2013, 35:592-597.
39. Inoue T., Tanaka T., Nakagawa S., Nakato Y., Kameyama R., Boku S., Toda H., Kurita T., Koyama T. Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care. BMC Psychiatry 2012, 12:1-6.
40. Karam E.G., Mneimneh Z.N., Dimassi H., Fayyad J.A., Karam A.N., Nasser S.C., Chatterji S., Kessler R.C. Lifetime prevalence of mental disorders in Lebanon: first onset, treatment, and exposure to war. PLoS Med. 2008, 5:579-586.
41. Karekla M., Pilipenko N., Feldman J. Patient Health Questionnaire: Greek language validation and subscale factor structure. Compr. Psychiatry 2012, 53:1217-1226.
42. Kazarian S.S., Taher D. Validation of the Arabic center for epidemiological studies depression (CES-D) scale in a Lebanese community sample. Eur. J. Psychol. Assess. 2010, 26:68-73.
43. Kendel F., Wirtz M., Dunkel A., Lehmkuhl E., Hetzer R., Regitz-Zagrosek V. Screening for depression: Rasch analysis of the dimensional structure of the PHQ-9 and the HADS-D. J. Affect Disord. 2010, 122:241-246.
44. Kertz S., Bigda-Peyton J., Bjorgvinsson T. Validity of the generalized anxiety disorder-7 scale in an acute psychiatric sample. Clin. Psychol. Psychother. 2012, 20:456-464.
45. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatr. 2005, 62:593-602.
46. Kocovski N.L., Endler N.S., Cox B.J., Swinson R.P. The differential assessment of state-trait anxiety and depression in a clinically anxious sample. J. Psychopathol. Behav. 2004, 26:165-172.
47. Konkan R., Şenormanici Ö., Güçülu O., Aydin E., Sungur M.Z. Validity and reliability study for the Turkish adaptation of the Generalized Anxiety Disorder-7 (GAD-7) scale. Arq. Neuropsiquiatr. 2013, 50:53-58.
48. Krause J.S., Bombardier C., Carter R.E. Assessment of depressive symptoms during inpatient rehabilitation for spinal cord injury: is there an underlying somatic factor when using the PHQ?. Rehabil. Psychol. 2008, 53:513-520.
49. Kroenke K., Spitzer R.L. The PHQ-9: A new depression diagnostic and severity measure. Psychiatr. Ann. 2002, 32:1-7.
50. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16:606-613.
51. Kroenke K., Spitzer R.L., Williams J.B.W., Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen. Hosp. Psychiatry 2010, 32:345-359.
52. Kroenke K., Spitzer R.L., Williams J.B.W., Monahan P.O., Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 2007, 146:317-325.
53. Löwe B., Decker O., Müller S., Brähler E., Schellberg D., Herzog W., Herzberg P.Y. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med. Care 2008, 46:266-274.
54. Löwe B., Spitzer R.L., Gräfe K., Kroenke K., Quenter A., Zipfel S., Buchholz C., Witte S., Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J. Affect. Disord. 2004, 78:131-140.
55. Mahfoud Z., Abdulrahim S., Taha M.B., Harpham T., El-Hajj T., Makhoul J., Nakkash R., Kanj M., Afifi R. Validation of the Arab youth mental health scale as a screening tool for depression/anxiety in Lebanese children. Child. Adolesc. Psychiatry Ment. Health 2011, 5:1-7.
56. Marc L.G., Henderson W.R., Desrosiers A., Testa M.A., Jean S.E., Akom E.E. Reliability and validity of the Haitian Creole PHQ-9. J. Gen. Intern. Med. 2014, 29:1679-1686.
57. Mahfoud Z., Kobeissi L., Peters T.J., Araya R., Ghantous Z., Khoury B. The Arabic validation of the Hopkins Symptoms Checklist-25 against MINI in a disadvantaged suburb of Beirut, Lebanon. Int. J. Educ. Psychol. Assess. 2013, 13:17-33.
58. Martin A., Rief W., Klaiberg A., Braehler E. Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. Gen. Hosp. Psychiatry 2006, 28:71-77.
59. Maters G.A., Sanderman R., Kim A.Y., Coyne J.C. Problems in cross-cultural use of the hospital anxiety and depression scale: "No butterflies in the desert. PLoS One 2013, 8:1-11.
60. McGuire A.W., Eastwood J.A., Macabasco-O'Connell A., Hays R.D., Doering L.V. Depression screening: Utility of the patient health questionnaire in patients with acute coronary syndrome. Am. J. Crit. Care 2013, 22:12-19.
61. Monahan P.O., Shacham E., Reece M., Kroenke K., Ong'or W.O., Omollo O., Yebei V.N., Ojwang C. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in Western Kenya. J. Gen. Intern. Med. 2008, 24:189-197.
62. Navinés R., Castellví P., Moreno-España J., Gimenez D., Udina M., Cañizares S., Diez-Quevedo C., Valdés M., Solà R., Martín-Santos R. Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health Questionnaire. J. Affect. Disord. 2012, 138:343-351.
63. Osório F.D., Mendes A.V., Crippa J.A., Loureiro S.R. Study of the Discriminative Validity of the PHQ-9 and PHQ-2 in a sample of Brazilian women in the context of primary health care. Perspect. Psychiatr. C 2009, 45:216-227.
64. Persoons P., Luyckx K., Desloovere C., Vandenberghe J., Fischler B. Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: Validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology. Gen. Hosp. Psychiatry 2003, 25:316-323.
65. Reda A.A. Reliability and validity of the Ethiopian version of the hospital anxiety and depression scale (HADS) in HIV infected patients. PLoS One 2011, 6:1-6.
66. Ryding K.C. Proficiency despite diglossia: A new approach for Arabic. Mod. Lang. J. 1991, 75:212-218.
67. Sidik S.M., Arroll B., Goodyear-Smith F. Validation of the GAD -7 (Malay version) among women attending a primary care clinic in Malaysia. J. Prim. Health Care 2012, 4:5-11.
68. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 2006, 166:1092-1097.
69. Spitzer R.L., Kroenke K., Williams J.B.W. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. JAMA 1999, 282:1737-1744.
70. Taouk, M., Lovibond, P.F., Laube, R., 2001. Psychometric properties of an Arabic version of the Depression Anxiety Stress Scales (DASS21). Report for New South Wales Transcultural Mental Health Centre, Cumberland Hospital, Sydney.
71. Thekkumpurath P., Walker J., Butcher I., Hodges L., Kleiboer A., O'Connor M., Wall L., Murray G., Kroenke K., Sharpe M. Screening for major depression in cancer patients: The diagnostic accuracy of the 9-item patient health questionnaire. Cancer 2011, 117:218-227.
72. van de Vijver F.J.R., Poortinga Y. Conceptual and Methodological Issues in Adapting Tests. Adapting educational and psychological tests for cross-cultural assessment 2005, 39-63. Lawrence Erlbaum Associates, Mahwah. R.K. Hambleton, P.F. Merenda, C.D. Spielberger (Eds.).
73. Watson D., Weber K., Assenheimer J.S., Clark L.A., Strauss M.E., McCormick R.A. Testing a tripartite model: I. evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J. Abnorm. Psychol. 1995, 104:3-14.
74. Wetherell J.L., Gatz M. The beck anxiety inventory in older adults with generalized anxiety disorder. J. Psychopathol. Behav. Assess. 2005, 27:17-24.
75. Williams R.T., Bode R.K., Fann J.R., Heinemann A.W., Wilson C.S., Tate D.G. Improving measurement properties of the patient health questionnaire - 9 with rating scale analysis. Rehabil. Psychol. 2009, 54:198-203.
76. Wittkampf K.A., Naeije L., Schene A.H., Huyser J., van Weert H.C. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen. Hosp. Psychiatry 2007, 29:388-395.
77. Zeinoun P., Bawab S., Atwi M., Hariz N., Tavitian L., Khani M., Maalouf F.T. Validation of an Arabic multi-informant psychiatric diagnostic interview for children and adolescents: development and Well Being Assessment-Arabic (DAWBA-Arabic). Compr. Psychiatry 2013, 54:1034-1041.
78. Zhang Y., Ting R., Lam M., Lam J., Nan H., Yeung R., Yang W., Ji L., Weng J., Wing Y.K., Sartorius N., Chan J.C.N. Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes. J. Affect. Disord. 2013, 151:660-666.